📚 Le premier MOOC d'une série intitulé “Diagnosing Rare Diseases: from the Clinic to Research and back” est ouvert aux inscriptions ! @EJPRareDiseases
▶️ La première session commencera le 26 avril 2021.
Inscrivez vous ici : https://t.co/9pw3s6PJoU
EATRIS is a partner in Translation Together - a unique global collaboration of leading #TranslationalScience organisations with the aim of advancing the science & understanding of biomedical translation.
See the new website and video here: https://t.co/Bgq48SRxdd
Last contribution before graduation. @MasterEMMRI was fantastic opportunity with great learning experience. Thanks @EatrisEric for this opportunity, Master faculty and Master students for the brilliant expertise and best practices sharing!
@MPasterk@MasterEMMRI@EatrisEric Thank you Markus for your guidance and expertise during this 2-year Master programme. Was great having you as advisor for my field project and as faculty member!
We've signed a Memorandum of Understanding with @CPathInstitute to accelerate drug development for rare diseases by increasing the efficiency of translation of potential therapeutics through preclinical and clinical development. More here: https://t.co/hYWtBxsTln
We kicked-off the Translation Together annual event with a session dedicated to putting Translation Science on the global stage. Florence (Head of Operations @EatrisEric) sums it up here. Read more about Translation Together here: https://t.co/epXDivCm0O #TranslationalMedicine
"Let’s unite and win this battle" a message from Toni Andreu, Scientific Director of EATRIS.
He has been volunteering as a physician at a nursing home to assist the resident physicians and nurses in Barcelona, Spain.
#covid19#volunteers#physicians#nurses
In Munich for the PEMED conference 2020. Looking forward to present EATRIS-plus multi-omic toolbox to support researchers with their PM development programme. @EatrisEric
@pemed_precision programme is available https://t.co/FG5xtfUIky. I will be presenting #EATRIS actions in Personalised Medicine development. The session is dedicated to cutting-edge strategies and solution (Munich, Feb 21). Hope to see you there!#PrecisionMedicine
Define the future of drug development by creating patient-focused and cross-company collaborative platform trials: That is the goal of the EU-PEARL project (@imi_eupearl) which we are excited to co-coordinate!
Press release: https://t.co/uX6Uu2AqjR
@VHIR_@EFPIA @IMI_JU
Biomarkers to predict treatment responses, longitudinal data and disease natural history are urgently needed for new #paediatric interventions. One of the important point being raised today at the @EFPIA and @EFGCP workshop on peadiatric unmet medical need.
#HorizonEU will be a role model turning excellent research results into sustainable solutions with economic value & societal benefits 🌍📈👨👩👧
EU valorisation policy will aim to boost the use & commercialisation of research results in the EU 🇪🇺
Learn more👉https://t.co/jkhvyxT6PW